
Oritavancin - Wikipedia
Oritavancin, sold under the brand name Orbactiv (by Melinta Therapeutics) among others, is a semisynthetic glycopeptide antibiotic medication for the treatment of serious Gram-positive bacterial infections.
Single-Dose Oritavancin in the Treatment of Acute Bacterial Skin ...
2014年6月5日 · Oritavancin is a lipoglycopeptide with bactericidal activity against gram-positive bacteria. Its concentration-dependent activity and prolonged half-life allow for single-dose treatment.
Oritavancin (intravenous route) - Mayo Clinic
2025年3月1日 · Oritavancin injection is used to treat acute bacterial skin and skin structure infections (ABSSSI). Oritavancin belongs to the group of medicines known as antibiotics. It works by killing bacteria or preventing their growth. Oritavancin …
Oritavancin Uses, Side Effects & Warnings - Drugs.com
What is oritavancin? Oritavancin is an antibiotic that is used to treat severe skin infections caused by bacteria. Oritavancin may also be used for purposes not listed in this medication guide.
Orbactiv® (oritavancin) for injection | Melinta Therapeutics, Inc.
ORBACTIV® (oritavancin) for injection is indicated for the treatment of adult patients with acute bacterial skin and skin structure infections (ABSSSI) caused or suspected to be caused by susceptible isolates of the following gram-positive microorganisms: Staphylococcus aureus (including methicillin-susceptible [MSSA] and -resistant [MRSA ...
Oritavancin (Orbactiv): A New-Generation Lipoglycopeptide for …
Oritavancin is a new-generation lipoglycopeptide indicated for the treatment of adults with acute bacterial skin and skin structure infections (ABSSSI) caused by susceptible organisms, including Staphylococcus aureus (methicillin-susceptible [MSSA] and methicillin-resistant [MRSA] strains), certain Streptococcus species, and Enterococcus ...
Oritavancin: Uses, Interactions, Mechanism of Action - DrugBank …
2007年10月21日 · Oritavancin is indicated for the treatment of adult patients with acute bacterial skin and skin structure (including subcutaneous) infection.
Oritavancin: A New Lipoglycopeptide Antibiotic in the Treatment …
Oritavancin is a semisynthetic lipoglycopeptide antibiotic that was recently approved for the treatment of acute bacterial skin and skin structure infections (ABSSSI).
The Clinical Efficacy of Multidose Oritavancin: A Systematic Review
Oritavancin (ORI) is a semisynthetic lipoglycopeptide approved as a single 1200 mg dose intravenous infusion for the treatment of acute bacterial skin and skin structure infections (ABSSSIs) caused by Gram-positive organisms in adults.
Oritavancin injection - Cleveland Clinic
ORITAVANCIN (ORE ita van sin) is an antibiotic. It is used to treat certain kinds of bacterial infections. It will not work for colds, flu, or other viral infections.